These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9486849)

  • 21. RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
    Petiniot LK; Weaver Z; Vacchio M; Shen R; Wangsa D; Barlow C; Eckhaus M; Steinberg SM; Wynshaw-Boris A; Ried T; Hodes RJ
    Mol Cell Biol; 2002 May; 22(9):3174-7. PubMed ID: 11940674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterification steps of V(D)J recombination.
    Swanson PC
    Mol Cell Biol; 2001 Jan; 21(2):449-58. PubMed ID: 11134333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
    Guidos CJ; Williams CJ; Grandal I; Knowles G; Huang MT; Danska JS
    Genes Dev; 1996 Aug; 10(16):2038-54. PubMed ID: 8769647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transrearrangements as biomarkers for risk of lymphoid malignancy.
    Kirsch IR; Lista F
    Cancer Surv; 1996; 28():311-27. PubMed ID: 8977043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accessibility control of V(D)J recombination.
    Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
    Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice.
    Lam QL; Lo CK; Zheng BJ; Ko KH; Osmond DG; Wu GE; Rottapel R; Lu L
    Int Immunol; 2007 Mar; 19(3):267-76. PubMed ID: 17229817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
    Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VDJ recombination.
    Alt FW; Oltz EM; Young F; Gorman J; Taccioli G; Chen J
    Immunol Today; 1992 Aug; 13(8):306-14. PubMed ID: 1510813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New concepts in the regulation of an ancient reaction: transposition by RAG1/RAG2.
    Chatterji M; Tsai CL; Schatz DG
    Immunol Rev; 2004 Aug; 200():261-71. PubMed ID: 15242411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
    Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R
    Cancer Res; 2007 Sep; 67(18):8527-35. PubMed ID: 17875692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
    Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
    Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 mutations in C57BL/6J murine thymic lymphomas induced by gamma-irradiation and N-methylnitrosourea.
    Brathwaite O; Bayona W; Newcomb EW
    Cancer Res; 1992 Jul; 52(13):3791-5. PubMed ID: 1617648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of V(D)J recombination in double-strand break repair mutants.
    Taccioli GE; Rathbun G; Oltz E; Stamato T; Jeggo PA; Alt FW
    Science; 1993 Apr; 260(5105):207-10. PubMed ID: 8469973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-irradiation directly affects the formation of coding joints in SCID cell lines.
    Binnie A; Olson S; Wu GE; Lewis SM
    J Immunol; 1999 Nov; 163(10):5418-26. PubMed ID: 10553067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
    De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
    Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice.
    Buettner VL; Hill KA; Nishino H; Schaid DJ; Frisk CS; Sommer SS
    Oncogene; 1996 Dec; 13(11):2407-13. PubMed ID: 8957082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The RAG2 C terminus suppresses genomic instability and lymphomagenesis.
    Deriano L; Chaumeil J; Coussens M; Multani A; Chou Y; Alekseyenko AV; Chang S; Skok JA; Roth DB
    Nature; 2011 Mar; 471(7336):119-23. PubMed ID: 21368836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant V(D)J cleavages in T cell receptor beta enhancer- and p53-deficient lymphoma cells.
    Kang YH; Son CY; Lee CH; Ryu CJ
    Oncol Rep; 2010 May; 23(5):1463-8. PubMed ID: 20372865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinase activating gene expression in thymic subpopulations. A transitional cell type has lost RAG-2 but not RAG-1.
    Campbell JJ; Hashimoto Y
    J Immunol; 1993 Feb; 150(4):1307-13. PubMed ID: 8432979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
    Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
    Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.